Now showing items 1-3 of 3

    • Córdova Delgado, Miguel Angel; Bravo, María Loreto; Cumsille, Elisa; Hill, Charlotte N.; Muñoz Medel, Matías; Pinto, Mauricio P.; Retamal, Ignacio N.; Lavanderos, María; Miquel, Juan Francisco; Rodríguez Fernández, María (BMC, 2021)
      Background: Fluoropyrimidine plus platinum chemotherapy remains the standard first line treatment for gastric cancer (GC). Guidelines exist for the clinical interpretation of four DPYD genotypes related to severe ...
    • Orellana, Renán; Kato, Sumie; Erices, Rafaela; Bravo, María Loreto; González, Pamela; Oliva, Bárbara; Cubillos, Sofía; Valdivia, Andrés; Ibáñez, Carolina; Brañes, Jorge; Barriga, María Isabel; Bravo, Erasmo; Alonso, Catalina; Bustamente, Eva; Castellón, Enrique; Hidalgo, Patricia; Trigo, César; Panes, Olga; Pereira, Jaime; Mezzano, Diego; Cuello, Mauricio A.; Owen, Gareth I. (BioMed Central, 2015)
      Background: An increase in circulating platelets, or thrombocytosis, is recognized as an independent risk factor of bad prognosis and metastasis in patients with ovarian cancer; however the complex role of platelets in ...
    • Salvo, Mauricio; González Feliu, Evelin; Toro, Jéssica; Gallegos Méndez, Iván; Maureira Caviedes, Ignacio Andrés; Miranda González, Nicolás; Barajas Barajas, Olga Beatriz; Bustamante, Eva; Ahumada Olea, Mónica Beatriz; Colombo Flores, Alicia Angelina; Armisen, Ricardo; Villaman, Camilo; Ibáñez, Carolina; Bravo, María Loreto; Sanhueza, Verónica; Spencer, M. Loreto; Toro, Gonzalo de; Morales, Erik; Bizama, Carolina; García, Patricia; Carrasco, Ana María; Gutiérrez Cordero, Lorena; Bermejo, Justo; Verdugo Salgado, Ricardo Alejandro; Marcelain Cubillos, Katherine Jenny (MDPI, 2021)
      Next-generation sequencing (NGS) is progressively being used in clinical practice. However, several barriers preclude using this technology for precision oncology in most Latin American countries. To overcome some of these ...